A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
This trial is active, not recruiting.
|Conditions||gastric cancer, pancreatic cancer|
|Treatment||questionnaire, blood specimens|
|Sponsor||Memorial Sloan Kettering Cancer Center|
|Start date||August 2008|
|End date||August 2017|
|Trial size||300 participants|
|Trial identifier||NCT00745381, 08-105|
The purpose of this study is to establish a neuroendocrine tumor registry. A registry is a collection of information. To create this registry, the investigators would like to get information, blood and tumor samples from people with neuroendocrine tumors. By collecting this information and material, the investigators are hoping to learn more about the genetic causes of neuroendocrine tumors. All of this will help us to better understand neuroendocrine cancer, so the investigators can find better ways to treat and diagnose this disease. DNA will be taken from the blood samples and will be used in future studies. This will be an important resource from which the investigators can study genes that may be related to a higher risk of neuroendocrine tumors.
The information collected will include medical information, family history of cancer and your answers to questions about how the cancer affects quality of life.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Basking Ridge, NJ||Memorial Sloan-Kettering Cancer Center at Basking Ridge||no longer recruiting|
|Commack, NY||Memorial Sloan-Kettering Cancer Center at Commack||no longer recruiting|
|New York, NY||Memorial Sloan Kettering Cancer Center||no longer recruiting|
To develop a tissue, serum, plasma and DNA bank from individuals with NET. This bank will be combined with epidemiologic and clinical information to create a NET database.
time frame: conclusion of the study
Male or female participants at least 18 years old.
Inclusion Criteria: - Diagnosis of gastroenteropancreatic neuroendocrine tumors or neuroendocrine tumors of unknown primary - Willing to donate blood samples - >= 18years old - Patients may have received prior hormonal therapy, cytotoxic therapy, irradiation, immunotherapy or surgical therapy Exclusion Criteria: - Have any condition, which in the opinion of the primary MSKCC clinician or investigators precludes their ability to provide informed consent
|Official title||Gastroenteropancreatic and Unknown Primary Neuroendocrine Registry A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors|
|Principal investigator||Diane Reidy-Lagunes, MD|
Call for more information